Costimulation via CD55 on human CD4+ T cells mediated by CD97

被引:91
作者
Capasso, Melania
Durrant, Lindy G.
Stacey, Martin
Gordon, Siamon
Ramage, Judith
Spendlove, Ian [1 ]
机构
[1] Univ Nottingham, City Hosp, Acad Dept Clin Oncol, Inst Infect Immun & Inflammat, Nottingham NG5 1PB, England
[2] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 2JD, England
基金
英国医学研究理事会;
关键词
D O I
10.4049/jimmunol.177.2.1070
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Decay-accelerating factor (CD55) is a complement regulatory protein, which is expressed by most cells to protect them from complement-mediated attack. CD55 also binds CD97, an EGF-TM7 receptor constitutively expressed on granulocytes and monocytes and rapidly up-regulated on T and B cells upon activation. Early results suggested that CD55 could further enhance T cell proliferation induced by phorbol ester treatment. The present study demonstrates that coengagement of CD55, using either cross-linking mAbs or its natural ligand CD97, and CD3 results in enhanced proliferation of human peripheral blood CD4(+) T cells, expression of the activation markers CD69 and CD25, and secretion of IL-10 and GM-CSF. Recently, an increase in T cell responsiveness in CD55(-/-) mice was shown to be mediated by a lack of complement regulation. In this study, we show that direct stimulation of CD55 on CD4(+) T cells with CD97 can modulate T cell activation but does not interfere with CD55-mediated complement regulation. Our results support a multifaceted role for CD55 in human T cell activation, constituting a further link between innate and adaptive immunity.
引用
收藏
页码:1070 / 1077
页数:8
相关论文
共 40 条
[1]   COXSACKIEVIRUS B3 ADAPTED TO GROWTH IN RD CELLS BINDS TO DECAY-ACCELERATING FACTOR (CD55) [J].
BERGELSON, JM ;
MOHANTY, JG ;
CROWELL, RL ;
JOHN, NFS ;
LUBLIN, DM ;
FINBERG, RW .
JOURNAL OF VIROLOGY, 1995, 69 (03) :1903-1906
[2]   DECAY-ACCELERATING FACTOR (CD55), A GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED COMPLEMENT REGULATORY PROTEIN, IS A RECEPTOR FOR SEVERAL ECHOVIRUSES [J].
BERGELSON, JM ;
CHAN, M ;
SOLOMON, KR ;
STJOHN, NF ;
LIN, HM ;
FINBERG, RW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (13) :6245-6248
[3]   Natural versus adaptive regulatory T cells [J].
Bluestone, JA ;
Abbas, AK .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (03) :253-257
[4]   Cutting edge: B7/CD28 interactions regulate cell cycle progression independent of the strength of TCR signaling [J].
Bonnevier, JL ;
Mueller, DL .
JOURNAL OF IMMUNOLOGY, 2002, 169 (12) :6659-6663
[5]  
COYNE KE, 1992, J IMMUNOL, V149, P2906
[6]  
DAVIS LS, 1988, J IMMUNOL, V141, P2248
[7]   CHARACTERIZATION OF AN EARLY ACTIVATION-DEPENDENT ANTIGEN ON LYMPHOCYTES DEFINED BY THE MONOCLONAL-ANTIBODY BL-AC(F2) [J].
EICHLER, W ;
AUST, G ;
HAMANN, D .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1994, 39 (01) :111-115
[8]   Expression characteristics of the human CD97 antigen [J].
Eichler, W ;
Hamann, J ;
Aust, G .
TISSUE ANTIGENS, 1997, 50 (05) :429-438
[9]   ANTI-TUMOR REACTIONS OF MONOCLONAL-ANTIBODY AGAINST A HUMAN OSTEOGENIC-SARCOMA CELL-LINE [J].
EMBLETON, MJ ;
GUNN, B ;
BYERS, VS ;
BALDWIN, RW .
BRITISH JOURNAL OF CANCER, 1981, 43 (05) :582-587
[10]   Crry/p65, a membrane complement regulatory protein, has costimulatory properties on mouse T cells [J].
Fernández-Centeno, E ;
de Ojeda, G ;
Rojo, JM ;
Portolés, P .
JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4533-4542